175 related articles for article (PubMed ID: 32799782)
1. Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.
Wang W; Xie Y; Han X; Liu Y; Li P
Technol Cancer Res Treat; 2020; 19():1533033820935856. PubMed ID: 32799782
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.
Li X; Yang Y; Yi X
Technol Cancer Res Treat; 2020; 19():1533033820936770. PubMed ID: 32799769
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
Yu H; Peng S; Chen X; Han S; Luo J
J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis.
Zhang C; Chu M; Fan Y; Wu L; Li Z; Ma X; Zhuang W
J Clin Lab Anal; 2020 Sep; 34(9):e23400. PubMed ID: 32578294
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
Bao Y; Wei M; Ji X
J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
[TBL] [Abstract][Full Text] [Related]
6. PHD finger protein 19 expression in multiple myeloma: Association with clinical features, induction therapy outcome, disease progression, and survival.
Li Y; Gong J; Zhang L
J Clin Lab Anal; 2021 Sep; 35(9):e23910. PubMed ID: 34390275
[TBL] [Abstract][Full Text] [Related]
7. Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients.
Zhao P; Zhao X
J Clin Lab Anal; 2021 Nov; 35(11):e23924. PubMed ID: 34564896
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
Yin Y; Yang W; Zhang L; Liu K; Luo Z
Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.
Sedlarikova L; Gromesova B; Kubaczkova V; Radova L; Filipova J; Jarkovsky J; Brozova L; Velichova R; Almasi M; Penka M; Bezdekova R; Stork M; Adam Z; Pour L; Krejci M; Kuglík P; Hajek R; Sevcikova S
Eur J Haematol; 2017 Sep; 99(3):223-233. PubMed ID: 28543758
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma.
Wang ZL; Liu Y; Zhou YL; Li JL; Sun QY; Wu LX; Wen L; Lai YY; Liu YR; Chang YJ; Shi HX; Liu KY; Huang XJ; Lu J; Ruan GR
Eur J Haematol; 2020 Aug; 105(2):185-195. PubMed ID: 32282962
[TBL] [Abstract][Full Text] [Related]
11. Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.
Hose D; Rème T; Hielscher T; Moreaux J; Messner T; Seckinger A; Benner A; Shaughnessy JD; Barlogie B; Zhou Y; Hillengass J; Bertsch U; Neben K; Möhler T; Rossi JF; Jauch A; Klein B; Goldschmidt H
Haematologica; 2011 Jan; 96(1):87-95. PubMed ID: 20884712
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of beta-catenin in multiple myeloma].
Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma.
Zhou F; Wang D; Wei W; Chen H; Shi H; Zhou N; Wu L; Peng R
BMC Cancer; 2020 Jan; 20(1):40. PubMed ID: 31948430
[TBL] [Abstract][Full Text] [Related]
14. MMSA-1 expression pattern in multiple myeloma and its clinical significance.
Meng S; Lu C; Zhang W; Shen W; Wei Y; Su D; Zhou F
Clin Exp Med; 2016 Nov; 16(4):599-609. PubMed ID: 26493349
[TBL] [Abstract][Full Text] [Related]
15. Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients.
Ghermezi M; Li M; Vardanyan S; Harutyunyan NM; Gottlieb J; Berenson A; Spektor TM; Andreu-Vieyra C; Petraki S; Sanchez E; Udd K; Wang CS; Swift RA; Chen H; Berenson JR
Haematologica; 2017 Apr; 102(4):785-795. PubMed ID: 28034989
[TBL] [Abstract][Full Text] [Related]
16. Potentiality of Protein phosphatase Mg
Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
[TBL] [Abstract][Full Text] [Related]
18. Relationship of P-selectin glycoprotein ligand-1 to prognosis in patients with multiple myeloma.
Atalay F; Ateşoğlu EB; Yıldız S; Firatlı-Tuglular T; Karakuş S; Bayık M
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):164-70. PubMed ID: 25445472
[TBL] [Abstract][Full Text] [Related]
19. Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma.
Luo Y; Gui R
Turk J Haematol; 2020 Nov; 37(4):248-262. PubMed ID: 32812415
[TBL] [Abstract][Full Text] [Related]
20. High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma.
Huang LJ; Shen Y; Bai J; Wang FX; Feng YD; Chen HL; Peng Y; Zhang R; Li FM; Zhang PH; Lei XR; Xue F; Ma YP; Hu JS; He AL
Acta Haematol; 2020; 143(3):279-288. PubMed ID: 31597158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]